Literature DB >> 30603275

Risk factors for sudden death and cardiac arrest at the onset of fulminant type 1 diabetes mellitus.

Megu Yamaguchi Baden1, Akihisa Imagawa1, Hiromi Iwahashi1, Iichiro Shimomura1, Takuya Awata2, Hiroshi Ikegami3, Yasuko Uchigata4, Haruhiko Osawa5, Hiroshi Kajio6, Eiji Kawasaki7,8, Yumiko Kawabata3, Akira Shimada9, Kazuma Takahashi10, Shoichiro Tanaka11, Kazuki Yasuda12, Hisafumi Yasuda13, Tetsuro Kobayashi14, Toshiaki Hanafusa15.   

Abstract

AIMS: The onset of fulminant type 1 diabetes mellitus is sometimes accompanied by sudden death or cardiac arrest. The aim of this study was to determine the risk factors for the development of these conditions at the onset of fulminant type 1 diabetes mellitus.
METHODS: We conducted a search of the literature on fulminant type 1 diabetes and sudden death or cardiac arrest published up to 2012 in PubMed and Ichushi (a Japanese article database), and a questionnaire survey was administered to the authors of the articles and to diabetes specialists affiliated to the Japan Diabetes Society. We analyzed the clinical data at disease onset of 17 patients with fulminant type 1 diabetes mellitus who experienced sudden death or cardiac arrest, and those of 257 patients who did not develop these conditions.
RESULTS: Patients with sudden death or cardiac arrest were younger, had a higher rate of impaired consciousness, more severe acidosis, hyperglycemia, hyponatremia, hyperkalemia, and hypochloremia, a higher serum blood urea nitrogen level, a higher serum creatinine level, and a higher plasma osmolality level than the other patients. In multiple logistic regression analyses, plasma glucose level was positively associated with sudden death or cardiac arrest. Receiver operating characteristic curve analyses showed that patients with a plasma glucose level over 1000 mg/dl (55.5 mmol/l) were at a high risk of cardiac arrest.
CONCLUSIONS: Severe metabolic derangement, especially a high plasma glucose level, is associated with sudden death or cardiac arrest at the onset of fulminant type 1 diabetes mellitus.

Entities:  

Keywords:  Cardiac arrest; Fulminant type 1 diabetes mellitus; Risk factors; Sudden death

Year:  2015        PMID: 30603275      PMCID: PMC6224989          DOI: 10.1007/s13340-015-0247-6

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  22 in total

1.  Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome.

Authors:  N Sekine; T Motokura; T Oki; Y Umeda; N Sasaki; M Hayashi; H Sato; T Fujita; T Kaneko; Y Asano; K Kikuchi
Journal:  JAMA       Date:  2001-03-07       Impact factor: 56.272

2.  Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.

Authors:  C J Greenbaum; D Cuthbertson; J P Krischer
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

Review 3.  Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners.

Authors:  Toshiaki Hanafusa; Akihisa Imagawa
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-01

4.  Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment.

Authors:  K Sayama; A Imagawa; K Okita; S Uno; M Moriwaki; J Kozawa; H Iwahashi; K Yamagata; S Tamura; Y Matsuzawa; T Hanafusa; J Miyagawa; I Shimomura
Journal:  Diabetologia       Date:  2005-07-01       Impact factor: 10.122

Review 5.  Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection.

Authors:  Chien-Chun Chiou; Wen-Hung Chung; Shuen-Iu Hung; Li-Cheng Yang; Hong-Shang Hong
Journal:  J Am Acad Dermatol       Date:  2006-02       Impact factor: 11.527

6.  Encephalomyocarditis-virus-induced diabetes model resembles "fulminant" type 1 diabetes in humans.

Authors:  A Shimada; T Maruyama
Journal:  Diabetologia       Date:  2004-10-22       Impact factor: 10.122

7.  Fulminant type 1 diabetes: a nationwide survey in Japan.

Authors:  Akihisa Imagawa; Toshiaki Hanafusa; Yasuko Uchigata; Azuma Kanatsuka; Eiji Kawasaki; Tetsuro Kobayashi; Akira Shimada; Ikki Shimizu; Tetsuya Toyoda; Taro Maruyama; Hideichi Makino
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

8.  A case of fulminant type 1 diabetes mellitus after influenza B infection.

Authors:  Hiroyuki Sano; Jungo Terasaki; Chiharu Tsutsumi; Akihisa Imagawa; Toshiaki Hanafusa
Journal:  Diabetes Res Clin Pract       Date:  2008-01-04       Impact factor: 5.602

9.  A case of fulminant type 1 diabetes with transiently positive anti-GAD antibodies.

Authors:  Taisuke Iwaoka
Journal:  Endocr J       Date:  2003-04       Impact factor: 2.349

10.  Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes.

Authors:  Y M Cho; J T Kim; K S Ko; B K Koo; S W Yang; M H Park; H K Lee; K S Park
Journal:  Diabetologia       Date:  2007-08-28       Impact factor: 10.122

View more
  2 in total

1.  Type 1 diabetes associated with immune checkpoint inhibitors for malignant melanoma: A case report and review of 8 cases.

Authors:  Akihiro Ishiguro; Dai Ogata; Ken Ohashi; Kojiro Hiki; Kohei Yamakawa; Shunichi Jinnai; Keita Tsutsui; Akira Takahashi; Kenjiro Namikawa; Naoya Yamazaki
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

2.  Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy.

Authors:  Megu Yamaguchi Baden; Akihisa Imagawa; Norio Abiru; Takuya Awata; Hiroshi Ikegami; Yasuko Uchigata; Yoichi Oikawa; Haruhiko Osawa; Hiroshi Kajio; Eiji Kawasaki; Yumiko Kawabata; Junji Kozawa; Akira Shimada; Kazuma Takahashi; Shoichiro Tanaka; Daisuke Chujo; Tomoyasu Fukui; Junnosuke Miura; Kazuki Yasuda; Hisafumi Yasuda; Tetsuro Kobayashi; Toshiaki Hanafusa
Journal:  Diabetol Int       Date:  2018-07-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.